David M. Epstein's Net Worth
$4.83 Million
Who is David M. Epstein?
David M. Epstein has an estimated net worth of $4.83 Million. This is based on reported shares across multiple companies, which include MetaStat, Inc., Black Diamond Therapeutics, Inc., and OSI PHARMACEUTICALS INC.
SEC CIK
David M. Epstein's CIK is 0001488668
Past Insider Trading and Trends
2020 was David M. Epstein's most active year for acquiring shares with 8 total transactions. David M. Epstein's most active month to acquire stocks was the month of January. 2020 was David M. Epstein's most active year for disposing of shares, totalling 12 transactions. David M. Epstein's most active month to dispose stocks was the month of May. 2014 saw David M. Epstein paying a total of $250,000.30 for 469,708 shares, this is the most they've acquired in one year. In 2010 David M. Epstein cashed out on 76,588 shares for a total of $4,404,870.02, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MetaStat, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +110.50% | 332.21K |
$1.10 | $250,000.30 | 632.84K |
Jun 30 - Oct 14
| |||
Form 4
| +12.50% | 12.5K |
—
|
—
| 112.5K |
Jul 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Black Diamond Therapeutics, Inc. (BDTX) Snapshot price: $3.8593
SEE REMARKS
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.59% | -25.00K |
$6.70 | -$167,500.00 | 671.42K |
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
| -1.28% | -9.00K |
$18.77 | -$354,244.94 | 696.42K |
Scheduled
|
Jan 4
| ||
Form 4
| +0.36% | 2.5K |
$6.42 | $16,050.00 | 705.42K |
Dec 15
| |||
Form 4
| -1.26% | -9.00K |
$19.57 | -$373,313.74 | 702.92K |
Scheduled
|
Dec 1
| ||
Form 4
| -1.25% | -9.00K |
$18.78 | -$354,396.39 | 711.92K |
Scheduled
|
Nov 2
| ||
Form 4
| -1.23% | -9.00K |
$18.38 | -$344,702.40 | 720.92K |
Scheduled
|
Oct 1
| ||
Form 4
| +56.01% | 270.35K |
—
|
—
| 753.01K |
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OSI PHARMACEUTICALS INC No price found
Sr. VP and CSO, Oncology
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -8.00 |
$57.50 | -$460.00 |
0
|
Jun 7
| |||
Form 4
| -99.94% | -13.34K |
$57.50 | -$767,050.00 | 8 |
Jun 3
| |||
Form 4
| -6.36% | -906.00 |
$58.67 | -$53,155.02 | 13.34K |
May 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||